Document is current
Any future updates will be listed below
-
Authors
Martelin, Eeva
Kuikka, Arttu
Rajala, Hanna
Ruohonen, Tuomas
Mönkkönen, Hannu
Vikkula, Johanna
Uusi-Rauva, Kristiina
Salmenniemi, Urpu
Itälä-Remes, Maija
- License Information
-
More Information
Article History
Received: 14 March 2025
Accepted: 25 May 2025
First Online: 6 June 2025
Declarations
:
: Not applicable. This study was approved by the Finnish Social and Health Data Permit Authority, Findata, in accordance with the Act on Secondary Use of Health and Social Data.
: A.K., E.M., H.R. and T.R. have nothing to declare. H.M. is employed by Novartis Finland Oy. J.V. and K.U-R. are employed by Medaffcon Oy (Espoo, Finland), which received payments from Novartis for conducting the study. U.S. has been a member of advisory boards for Takeda, AstraZeneca, and Immedica, and provided consultancy to Viatris. M.I-R. has been a member of an advisory board for Novartis and provided consultancy to Incyte.
